The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma
Open accessAbstract
Advanced cholangiocarcinoma continues to harbor a difficult prognosis and therapeutic options have been limited. During the course of a clinical trial of whole genomic sequencing seeking druggable targets, we examined six patients with advanced cholangiocarcinoma. Integrated genome-wide and whole transcriptome sequence analyses were performed on tumors from six patients with advanced, sporadic intrahepatic cholangiocarcinoma (SIC) to identify potential therapeutically actionable events. Among the somatic events captured in our analysis, we uncovered two novel therapeutically relevant genomic contexts that when acted upon, resulted in preliminary evidence of anti-tumor activity. Genome-wide structural analysis of sequence data revealed recurrent translocation events involving the FGFR2 locus in three of six assessed patients. These observations and supporting evidence triggered the use of FGFR inhibitors in these patients. In one example, preliminary anti-tumor activity of pazopanib (in vitro FGFR2 IC50≈350 nM) was noted in a patient with an FGFR2-TACC3 fusion. After progression on pazopanib, the same patient also had stable disease on ponatinib, a pan-FGFR inhibitor (in vitro, FGFR2 IC50≈8 nM). In an independent non-FGFR2 translocation patient, exome and transcriptome analysis revealed an allele specific somatic nonsense mutation (E384X) in ERRFI1, a direct negative regulator of EGFR activation. Rapid and robust disease regression was noted in this ERRFI1 inactivated tumor when treated with erlotinib, an EGFR kinase inhibitor. FGFR2 fusions and ERRFI mutations may represent novel targets in sporadic intrahepatic cholangiocarcinoma and trials should be characterized in larger cohorts of patients with these aberrations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A method and server for predicting damaging missense mutations.
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010) · Nature Methods · doi:10.1038/nmeth0410-248 · Cited by 13,194
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Valle, J., Wasan, H., Palmer, D. H., Cunningham, D., Anthoney, A., Maraveyas, A., Madhusudan, S., Iveson, T., Hughes, S., Pereira, S. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908721 · Cited by 4,406
MutationTaster evaluates disease-causing potential of sequence alterations
Schwarz, J. M., Rödelsperger, C., Schuelke, M., & Seelow, D. (2010) · Nature Methods · doi:10.1038/nmeth0810-575 · Cited by 2,975
Fibroblast growth factor signalling: from development to cancer
Turner, N., & Grose, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2780 · Cited by 2,693
Predicting Deleterious Amino Acid Substitutions
Ng, P. C., & Henikoff, S. (2001) · Genome Research · doi:10.1101/gr.176601 · Cited by 2,368
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Initiative, A. P. C. G., Biankin, A. V., Waddell, N., Kassahn, K. S., Gingras, M.-C., Muthuswamy, L. B., Johns, A. L., Miller, D. K., Wilson, P. J., Patch, A.-M., et al. (2012) · Nature · doi:10.1038/nature11547 · Cited by 2,058
Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Maad, I. B., Calderaro, J., Bioulac-Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,453
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
Cavallaro, U., & Christofori, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1276 · Cited by 1,311
Khan, S. A., Thomas, H. C., Davidson, B. R., & Taylor-Robinson, S. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67530-7 · Cited by 1,042
TopHat-Fusion: an algorithm for discovery of novel fusion transcripts
Kim, D., & Salzberg, S. L. (2011) · Genome Biology · doi:10.1186/gb-2011-12-8-r72 · Cited by 809
Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma
Singh, D., Chan, J. M., Zoppoli, P., Niola, F., Sullivan, R., Castano, A., Liu, E. M., Reichel, J., Porrati, P., Pellegatta, S., et al. (2012) · Science · doi:10.1126/science.1220834 · Cited by 789
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
Wu, Y.-M., Su, F., Kalyana-Sundaram, S., Khazanov, N., Ateeq, B., Cao, X., Lonigro, R. J., Vats, P., Wang, R., Lin, S.-F., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0050 · Cited by 744
Borger, D. R., Tanabe, K. K., Fan, K. C., Lopez, H. U., Fantin, V. R., Straley, K. S., Schenkein, D. P., Hezel, A. F., Ancukiewicz, M., Liebman, H. M., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0386 · Cited by 728
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis
Bergquist, A., Ekbom, A., Olsson, R., Kornfeldt, D., Lööf, L., Danielsson, Å., Hultcrantz, R., Lindgren, S., Prytz, H., Sandberg-Gertzén, H., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00288-4 · Cited by 717
Qi, J. H., Ebrahem, Q., Moore, N., Murphy, G., Claesson-Welsh, L., Bond, M., Baker, A., & Anand-Apte, B. (2003) · Nature Medicine · doi:10.1038/nm846 · Cited by 658
Self-citationdeFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data
McPherson, A., Hormozdiari, F., Zayed, A., Giuliany, R., Ha, G., Sun, M. G. F., Griffith, M., Heravi Moussavi, A., Senz, J., Melnyk, N., et al. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1001138 · Cited by 557 · cited 1×
“0 [108] used in patients 2, 3 and 5 and SnowShoes [109] for patients 2 and 5.”
MethodIncidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis
Burak, K., Angulo, P., Pasha, T. M., Egan, K., Petz, J., & Lindor, K. D. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04067.x · Cited by 557
Arai, Y., Totoki, Y., Hosoda, F., Shirota, T., Hama, N., Nakamura, H., Ojima, H., Furuta, K., Shimada, K., Okusaka, T., et al. (2014) · Hepatology · doi:10.1002/hep.26890 · Cited by 553
Risk factors of intrahepatic cholangiocarcinoma in the United States: A case-control study
Shaib, Y. H., El-Serag, H. B., Davila, J. A., Morgan, R., & McGlynn, K. A. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.048 · Cited by 546
Kumar, R., Knick, V. B., Rudolph, S. K., Johnson, J. H., Crosby, R. M., Crouthamel, M.-C., Hopper, T. M., Miller, C. G., Harrington, L. E., Onori, J. A., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0193 · Cited by 517
Welzel, T. M., Graubard, B. I., El–Serag, H. B., Shaib, Y. H., Hsing, A. W., Davila, J. A., & McGlynn, K. A. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.05.020 · Cited by 514
Exome sequencing of liver fluke–associated cholangiocarcinoma
Ong, C. K., Subimerb, C., Pairojkul, C., Wongkham, S., Cutcutache, I., Yu, W., McPherson, J. R., Allen, G. E., Ng, C. C. Y., Wong, B. H., et al. (2012) · Nature Genetics · doi:10.1038/ng.2273 · Cited by 486
High lifetime risk of cancer in primary sclerosing cholangitis
Claessen, M. M. H., Vleggaar, F. P., Tytgat, K. M. A. J., Siersema, P. D., & van Buuren, H. R. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.013 · Cited by 412
Wang, P., Dong, Q., Zhang, C., Kuan, P.-F., Liu, Y., Jeck, W. R., Andersen, J. B., Jiang, W., Savich, G. L., Tan, T.-X., et al. (2013) · Oncogene · doi:10.1038/onc.2012.315 · Cited by 399
Oncogenic FGFR3 gene fusions in bladder cancer
Williams, S. V., Hurst, C. D., & Knowles, M. A. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds486 · Cited by 390
Severe Bile Salt Export Pump Deficiency: 82 Different ABCB11 Mutations in 109 Families
Strautnieks, S. S., Byrne, J. A., Pawlikowska, L., Cebecauerová, D., Rayner, A., Dutton, L., Meier, Y., Antoniou, A., Stieger, B., Arnell, H., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.038 · Cited by 384
Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface
Zhang, X., Pickin, K. A., Bose, R., Jura, N., Cole, P. A., & Kuriyan, J. (2007) · Nature · doi:10.1038/nature05998 · Cited by 357
FGFR Genetic Alterations Predict for Sensitivity to NVP-BGJ398, a Selective Pan-FGFR Inhibitor
Guagnano, V., Kauffmann, A., Wöhrle, S., Stamm, C., Ito, M., Barys, L., Pornon, A., Yao, Y., Li, F., Zhang, Y., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0210 · Cited by 347
Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma
Tannapfel, A., Sommerer, F., Benicke, M., Katalinic, A., Uhlmann, D., Witzigmann, H., Hauss, J., & Wittekind, C. (2003) · Gut · doi:10.1136/gut.52.5.706 · Cited by 343
Gozgit, J. M., Wong, M. J., Moran, L., Wardwell, S., Mohemmad, Q. K., Narasimhan, N. I., Shakespeare, W. C., Wang, F., Clackson, T., & Rivera, V. M. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0450 · Cited by 320
Survey of Tyrosine Kinase Signaling Reveals ROS Kinase Fusions in Human Cholangiocarcinoma
Gu, T.-L., Deng, X., Huang, F., Tucker, M., Crosby, K., Rimkunas, V., Wang, Y., Deng, G., Zhu, L., Tan, Z., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015640 · Cited by 307
Determinants of protein function revealed by combinatorial entropy optimization
Reva, B., Antipin, Y., & Sander, C. (2007) · Genome Biology · doi:10.1186/gb-2007-8-11-r232 · Cited by 306
Liver fluke-associated cholangiocarcinoma
Watanapa, P., & Watanapa, W. B. (2002) · British Journal of Surgery · doi:10.1046/j.1365-2168.2002.02143.x · Cited by 303
Bergquist, A., Glaumann, H., Persson, B., & Broomé, U. (1998) · Hepatology · doi:10.1002/hep.510270201 · Cited by 281
ChimeraScan: a tool for identifying chimeric transcription in sequencing data
Iyer, M. K., Chinnaiyan, A. M., & Maher, C. A. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr467 · Cited by 276
Mig6 is a negative regulator of EGF receptor–mediated skin morphogenesis and tumor formation
Ferby, I., Reschke, M., Kudlacek, O., Knyazev, P., Pantè, G., Amann, K., Sommergruber, W., Kraut, N., Ullrich, A., Fässler, R., et al. (2006) · Nature Medicine · doi:10.1038/nm1401 · Cited by 263
Cirulli, V., & Yebra, M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2142 · Cited by 256
Donato, F., Gelatti, U., Tagger, A., Favret, M., Ribero, M. L., Callea, F., Martelli, C., Savio, A., Trevisi, P., & Nardi, G. (2001) · Cancer Causes & Control · doi:10.1023/a:1013747228572 · Cited by 247
Kobayashi, M., Ikeda, K., Saitoh, S., Suzuki, F., Tsubota, A., Suzuki, Y., Arase, Y., Murashima, N., Chayama, K., & Kumada, H. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11<2471::aid-cncr7>3.0.co;2-t · Cited by 247
Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma
Kipp, B. R., Voss, J. S., Kerr, S. E., Barr Fritcher, E. G., Graham, R. P., Zhang, L., Highsmith, W. E., Zhang, J., Roberts, L. R., Gores, G. J., et al. (2012) · Human Pathology · doi:10.1016/j.humpath.2011.12.007 · Cited by 244
Self-citationSHIN, H.-R., LEE, C.-U., PARK, H.-J., SEOL, S.-Y., CHUNG, J.-M., CHOI, H.-C., AHN, Y.-O., & SHIGEMASTU, T. (1996) · International Journal of Epidemiology · doi:10.1093/ije/25.5.933 · Cited by 237
Craig, D. W., O'Shaughnessy, J. A., Kiefer, J. A., Aldrich, J., Sinari, S., Moses, T. M., Wong, S., Dinh, J., Christoforides, A., Blum, J. L., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0781 · Cited by 220 · cited 2×
“More importantly, using previously published methods [59], we identified molecular fusions involving FGFR2 that were felt to be therapeutically relevant in 3 patients.”
MethodSelf-citationMyelosuppression and kinase selectivity of multikinase angiogenesis inhibitors
Kumar, R., Crouthamel, M.-C., Rominger, D. H., Gontarek, R. R., Tummino, P. J., Levin, R. A., & King, A. G. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605366 · Cited by 218
Richelda, R., Ronchetti, D., Baldini, L., Cro, L., Viggiano, L., Marzella, R., Rocchi, M., Otsuki, T., Lombardi, L., Maiolo, A. T., et al. (1997) · Blood · doi:10.1182/blood.v90.10.4062 · Cited by 206
Tannapfel, A., Benicke, M., Katalinic, A., Uhlmann, D., Köckerling, F., Hauss, J., & Wittekind, C. (2000) · Gut · doi:10.1136/gut.47.5.721 · Cited by 193
CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer
Wang, X., Osada, T., Wang, Y., Yu, L., Sakakura, K., Katayama, A., McCarthy, J. B., Brufsky, A., Chivukula, M., Khoury, T., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq343 · Cited by 188
Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma
Yamamoto, S., Kubo, S., Hai, S., Uenishi, T., Yamamoto, T., Shuto, T., Takemura, S., Tanaka, H., Yamazaki, O., Hirohashi, K., et al. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02492.x · Cited by 187
A crucial role for Fgfr2-IIIb signalling in epidermal development and hair follicle patterning
Petiot, A., Conti, F. J. A., Grose, R., Revest, J.-M., Hodivala-Dilke, K. M., & Dickson, C. (2003) · Development · doi:10.1242/dev.00788 · Cited by 176
Feng, S., Wang, F., Matsubara, A., Kan, M., & McKeehan, W. L. (1997) · PubMed · Cited by 173
Tada, M., Omata, M., & Ohto, M. (1990) · PubMed · Cited by 170
Somatic Mutations of Epidermal Growth Factor Receptor in Bile Duct and Gallbladder Carcinoma
Leone, F., Cavalloni, G., Pignochino, Y., Sarotto, I., Ferraris, R., Piacibello, W., Venesio, T., Capussotti, L., Risio, M., & Aglietta, M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1692 · Cited by 170
Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers.
Yoshida, S., Todoroki, T., Ichikawa, Y., Hanai, S., Suzuki, H., Hori, M., Fukao, K., Miwa, M., & Uchida, K. (1995) · PubMed · doi:10.11501/3164579 · Cited by 168
Essential Roles of EphB Receptors and EphrinB Ligands in Endothelial Cell Function and Angiogenesis
Salvucci, O., & Tosato, G. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-386503-8.00002-8 · Cited by 164
Antonescu, C. R., Zhang, L., Nielsen, G. P., Rosenberg, A. E., Cin, P. D., & Fletcher, C. D. M. (2011) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20897 · Cited by 159
Nord, K. H., Sciot, R., Staaf, J., Heidenblad, M., Rydholm, A., Bauer, H. C. F., Åström, K., Domanski, H. A., Meis, J. M., Kindblom, L., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2513 · Cited by 157
Bai, A., Meetze, K. A., Vo, N. N. Y., Kollipara, S., Mazsa, E. K., Winston, W. M., Weiler, S., Poling, L. L., Chen, T., Ismail, N. S., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1489 · Cited by 151
Mutations of the DPC4/Smad4 gene in biliary tract carcinoma.
Hahn, S. A., Bartsch, D. K., Schroers, A., Galehdari, H., Becker, M. A., Ramaswamy, A., Schwarte‐Waldhoff, I., Maschek, H., & Schmiegel, W. (1998) · PubMed · Cited by 146
Feedback inhibition by RALT controls signal output by the ErbB network
Anastasi, S., Fiorentino, L., Fiorini, M., Fraioli, R., Sala, G., Castellani, L., Alemà, S., Alimandi, M., & Segatto, O. (2003) · Oncogene · doi:10.1038/sj.onc.1206516 · Cited by 140
Scheimann, A. O., Strautnieks, S. S., Knisely, A. S., Byrne, J. A., Thompson, R. J., & Finegold, M. J. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.02.030 · Cited by 138
Evidence that MIG-6 is a tumor-suppressor gene
Zhang, Y.-W., Staal, B., Su, Y., Swiatek, P. J., Zhao, P., Cao, B., Resau, J. H., Sigler, R. E., Bronson, R. T., & Woude, G. F. V. (2006) · Oncogene · doi:10.1038/sj.onc.1209790 · Cited by 135
Mig-6 controls EGFR trafficking and suppresses gliomagenesis
Ying, H., Zheng, H., Scott, K. L., Wiedemeyer, R., Yan, H., Lim, C., Huang, J. S., Dhakal, S., Ivanova, E. V., Xiao, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914930107 · Cited by 131
Ha, G., Park, J. S., & Breuer, E.-K. Y. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.013 · Cited by 130
Anastasi, S., Sala, G., Huiping, C., Caprini, E., Russo, G., Iacovelli, S., Lucini, F., Ingvarsson, S., & Segatto, O. (2005) · Oncogene · doi:10.1038/sj.onc.1208658 · Cited by 130
Maisonneuve, C., Guilleret, I., Vick, P., Weber, T., Andre, P., Beyer, T., Blum, M., & Constam, D. B. (2009) · Development · doi:10.1242/dev.038174 · Cited by 129
Frosi, Y., Anastasi, S., Ballarò, C., Varsano, G., Castellani, L., Maspero, E., Polo, S., Alemà, S., & Segatto, O. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201002032 · Cited by 125
Asmann, Y. W., Hossain, A., Necela, B. M., Middha, S., Kalari, K. R., Sun, Z., Chai, H. S., Williamson, D. W., Radisky, D. C., Schroth, G. P., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr362 · Cited by 115
Self-citationIntegrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes
Duncan, C. G., Killela, P. J., Payne, C. A., Lampson, B. L., Chen, W., Liu, J., Solomon, D. A., Waldman, T. A., Towers, A. J., Gregory, S. G., et al. (2010) · Oncotarget · doi:10.18632/oncotarget.137 · Cited by 114
Gene expression of O-GlcNAc cycling enzymes in human breast cancers
Krześlak, A., Forma, E., Bernaciak, M., Romanowicz, H., & Bryś, M. (2011) · Clinical and Experimental Medicine · doi:10.1007/s10238-011-0138-5 · Cited by 110
Gwak, G., Yoon, J., Shin, C. M., Ahn, Y. J., Chung, J., Kim, Y. A., Kim, T., & Lee, H. S. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-005-0016-1 · Cited by 108
Taniai, M., Higuchi, H., Burgart, L. J., & Gores, G. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36021 · Cited by 99
Ren, M., Qin, H., Ren, R., & Cowell, J. K. (2012) · Leukemia · doi:10.1038/leu.2012.188 · Cited by 97
Reschke, M., Ferby, I., Stępniak-Konieczna, E., Seitzer, N., Horst, D. A., Wagner, E. F., & Ullrich, A. (2009) · Hepatology · doi:10.1002/hep.23428 · Cited by 97
Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma
Deshpande, V., Nduaguba, A. M., Zimmerman, S. M., Kehoe, S. M., MacConaill, L. E., Lauwers, G. Y., Ferrone, C. R., Bardeesy, N. M., Zhu, A. X., & Hezel, A. F. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-60 · Cited by 96
Diep, C. H., Zucker, K. M., Hostetter, G. H., Watanabe, A. T., Hu, C., Muñoz, R. M., Hoff, D. D. V., & Han, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032783 · Cited by 95
Self-citationIacobuzio–Donahue, C. A., Song, J., Parmiagiani, G., Yeo, C. J., Hruban, R. H., & Kern, S. E. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1121-3 · Cited by 93
Jeong, J.-W., Lee, H. S., Lee, K. Y., White, L. D., Broaddus, R. R., Zhang, Y.-W., Vande Woude, G. F., Giudice, L. C., Young, S. L., Lessey, B. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903632106 · Cited by 92
Self-citationChase, A., Grand, F., & Cross, N. C. P. (2007) · Blood · doi:10.1182/blood-2007-02-074286 · Cited by 92
Rare PIK3CA hotspot mutations in carcinomas of the biliary tract
Riener, M., Bawohl, M., Clavien, P., & Jochum, W. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20540 · Cited by 92
Kraus, M. R.-C., Clauin, S., Pfister, Y., Maïo, M. D., Ulinski, T., Constam, D. B., Bellanné‐Chantelot, C., & Grapin‐Botton, A. (2011) · Human Mutation · doi:10.1002/humu.21610 · Cited by 88
Kiba, T., Tsuda, H., Hirohashi, S., Inoue, S., Sügimura, T., & Pairojkul, C. (1993) · Molecular Carcinogenesis · doi:10.1002/mc.2940080415 · Cited by 87
Hsing, A. W., Zhang, M.-D., Rashid, A., McGlynn, K. A., Wang, B., Niwa, S., Ortiz‐Conde, B. A., Goedert, J. J., Fraumeni, J. F., OʼBrien, T. R., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23251 · Cited by 86
Christoforides, A., Carpten, J. D., Weiss, G. J., Demeure, M. J., Hoff, D. D. V., & Craig, D. W. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-302 · Cited by 86
Self-citationAspects of liver pathology in adult patients with MDR3/ABCB4 gene mutations
Wendum, D., Barbu, V., Rosmorduc, O., Arrivé, L., Fléjou, J., & Poupon, R. Y. (2012) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-012-1202-6 · Cited by 84
Ahrendt, S. A., Eisenberger, C. F., Yip, L., Rashid, A., Chow, J. T., Pitt, H. A., & Sidransky, D. (1999) · Journal of Surgical Research · doi:10.1006/jsre.1999.5615 · Cited by 82
Boberg, K. M., Schrumpf, E., Bergquist, A. M., Broomé, U., Parés, A. R., Remotti, H. E., Schjolberg, A., Spurkland, A., & Clausen, O. P. F. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80386-4 · Cited by 78
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Cholangiocarcinoma in patients with opisthorchiasis
Watanapa, P. (1996) · British journal of surgery · doi:10.1002/bjs.1800830809 · Cited by 69
Site-Specific Cancer Incidence and Mortality after Cerebral Angiography with Radioactive Thorotrast
Travis, L. B., Hauptmann, M., Gaul, L. K., Storm, H. H., GOLDMAN, M. B., Nyberg, U., Berger, E., Janower, M. L., Hall, P. N., Monson, R. R., et al. (2003) · Radiation Research · doi:10.1667/rr3095 · Cited by 64
Cross, N. C. P., & Reiter, A. (2008) · Acta Haematologica · doi:10.1159/000140631 · Cited by 64
Ballarò, C., Ceccarelli, S., Tiveron, C., Tatangelo, L., Salvatore, A. M., Segatto, O., & Alemà, S. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400458 · Cited by 47
Lin, C., Du, J., Shen, W. T., Whang, E. E., Donner, D. B., Griff, N., He, F., Moore, F. D., Clark, O. H., & Ruan, D. T. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1800 · Cited by 47
Downregulation of Mig‐6 in nonsmall‐cell lung cancer is associated with EGFR signaling
Li, Z., Dong, Q., Wang, Y., Qu, L., Qiu, X., & Wang, E. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20815 · Cited by 44
Src Activation Plays an Important Key Role in Lymphomagenesis Induced by FGFR1 Fusion Kinases
Ren, M., Qin, H., Ren, R., Tidwell, J. A., & Cowell, J. K. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1109 · Cited by 44
Becker, N., Liebermann, D., Wesch, H., & KAICK, G. V. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.02.050 · Cited by 44
Cancer-Type Regulation of MIG-6 Expression by Inhibitors of Methylation and Histone Deacetylation
Zhang, Y., Staal, B., Dykema, K. J., Furge, K. A., & Woude, G. F. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038955 · Cited by 22
Significance of keratinocyte growth factor receptor in the proliferation of biliary tract cancer.
Amano, R., Yamada, N., Doi, Y., Yashiro, M., Ohira, M., Miwa, A., & Hirakawa, K. (2010) · PubMed · Cited by 8
Cited by
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0310-z · Cited by 2,411
The Fibroblast Growth Factor signaling pathway
Ornitz, D. M., & Itoh, N. (2015) · WIREs Developmental Biology · doi:10.1002/wdev.176 · Cited by 2,050
Cholangiocarcinoma — evolving concepts and therapeutic strategies
Ilyas, S. I., Khan, S. A., Hallemeier, C. L., Kelley, R. K., & Gores, G. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.157 · Cited by 1,626
Banales, J. M., Cardinale, V., Carpino, G., Marzioni, M., Andersen, J. B., Invernizzi, P., Lind, G. E., Folseraas, T., Forbes, S. J., Fouassier, L., et al. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.51 · Cited by 1,376
Integrative omics for health and disease
Karczewski, K. J., & Snyder, M. P. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2018.4 · Cited by 1,158
Metadata
- Authors
- Borad, M. J., Champion, M. D., Egan, J. B., Liang, W. S., Fonseca, R., Bryce, A. H., McCullough, A. E., Barrett, M. T., Hunt, K., Patel, M. D., Young, S. W., Collins, J. M., Silva, A. C., Condjella, R. M., Block, M., McWilliams, R. R., Lazaridis, K. N., Klee, E. W., Bible, K. C., Harris, P., Oliver, G. R., Bhavsar, J. D., Nair, A. A., Middha, S., Asmann, Y., Kocher, J.-P., Schahl, K., Kipp, B. R., Barr Fritcher, E. G., Baker, A., Aldrich, J., Kurdoglu, A., Izatt, T., Christoforides, A., Cherni, I., Nasser, S., Reiman, R., Phillips, L., McDonald, J., Adkins, J., Mastrian, S. D., Placek, P., Watanabe, A. T., LoBello, J., Han, H., Von Hoff, D., Craig, D. W., Stewart, A. K., & Carpten, J. D.
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-02-13
- Volume
- 10
- Issue
- 2
- Pages
- e1004135
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- OpenAlex
- W2095046027
- Cited by
- 344
- References
- 96
- FWCI
- 33.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.